In previous studies in colorectal cancer, we showed that anti-CD133 ADC can internalise upon binding to CD133 on the cell surface and had cytotoxic and/or anti-proliferative activity against four out of 10 colorectal cancer cell lines tested (Van Orden et al, 2008). The gene discussed is PROM1; the disease is colorectal cancer.